Induction of hepatic mutations in lacI transgenic mice.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Mutagenesis

• Publication date

  1993-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/MUTAGE/8.3.265PMID 8332090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.

  1991cited by this paper
• Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse.

  1991cited by this paper
• Methylmethane-sulphonate and X-ray-induced mutations in the Chinese hamster hprt gene: mRNA phenotyping using polymerase chain reactions.

  1990cited by this paper
• Induction of specific-locus and dominant lethal mutations in male mice in the low dose range by methyl methanesulfonate (MMS).

  1990cited by this paper
• Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents.

  1990cited by this paper
• Mutagenesis of mouse intestine in vivo using the Dlb-1 specific locus test: studies with 1,2-dimethylhydrazine, dimethylnitrosamine, and the dietary mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.

  1990cited by this paper
• Mutational specificities of environmental carcinogens in the lacl gene of Escherichia coli. II: A host‐mediated approach to N‐nitroso‐N, N‐dimethylamine and endogenous mutagenesis in vivo

  1989cited by this paper
• The role of short-lived lesions in the induction of micronuclei in rat liver by ethylnitrosourea and methyl methanesulphonate: the importance of experimental design.

  1989cited by this paper
• A comparative study of hepatic DNA repair, DNA replication and hepatotoxicity in the CD-1 mouse following multiple administrations of dimethylnitrosamine.

  1987cited by this paper
• Induction of hepatic cell proliferation and unscheduled DNA synthesis in mouse hepatocytes following in vivo treatment.

  1985cited by this paper
• Induction of unscheduled DNA synthesis in primary cultures of rat pancreatic cells following in vivo and in vitro treatment with genotoxic agents.

  1984cited by this paper
• Assessment of chemically-induced DNA repair in rat tracheal epithelial cells.

  1984cited by this paper
• An assay to detect chemically induced DNA repair in rat spermatocytes.

  1984cited by this paper
• DNA repair synthesis in primary cultures of kidneys from BALB/c and C3H mice treated with dimethylnitrosamine.

  1978cited by this paper
• Tables for determining the statistical significance of mutation frequencies.

  1970cited by this paper
• Nitrosamine-induced carcinogenesis. The alklylation of nucleic acids of the rat by N-methyl-N-nitrosourea, dimethylnitrosamine, dimethyl sulphate and methyl methanesulphonate.

  1968cited by this paper

• Optimizing the detection of N-nitrosamine mutagenicity in the Ames test.

  2024cites this paper
• Risk assessment of N‐nitrosamines in food

  2023cites this paper
• AAV-Mig-6 Increase the Efficacy of TAE in VX2 Rabbit Model, Is Associated With JNK Mediated Autophagy

  2019cites this paper
• Assessment of methyl methanesulfonate using the repeated-dose liver micronucleus assay in young adult rats.

  2015cites this paper
• Metabolism, Genomics, and DNA Repair in the Mouse Aging Liver

  2011influential citation
• Toward a molecular equivalent dose: use of the medaka model in comparative risk assessment.

  2009cites this paper
• Dose-response relationships and potential thresholds in the induction of mutagenesis and the influence of DNA repair and cell cycle progression.

  2008cites this paper
• Transgenic animal mutagenicity assays

  2006cites this paper
• TRANSGENIC ANIMAL MUTAGENICITY ASSAYS

  2006cites this paper
• Mutagenicity testing with transgenic mice. Part II: Comparison with the mouse spot test

  2005cites this paper
• Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test

  2005cites this paper
• Mammary glands of sexually immature rats are more susceptible than those of mature rats to the carcinogenic, lethal, and mutagenic effects of N‐nitroso‐N‐methylurea

  2005influential citation
• Detailed review of transgenic rodent mutation assays.

  2005cites this paper
• DNA damage in lung after oral exposure to diesel exhaust particles in Big Blue rats.

  2004cites this paper
• Biomarkers of Cancer Risk and Therapeutic Benefit: New Technologies, New Opportunities, and Some Challenges

  2004cites this paper
• Analysis of mutations and bone marrow micronuclei in Big Blue rats fed leucomalachite green.

  2004cites this paper
• Mutational-reporter transgenes rescued from mice lacking either Mgmt, or both Mgmt and Msh6 suggest that O6-alkylguanine-induced miscoding does not contribute to the spontaneous mutational spectrum

  2004cites this paper
• Proof of principle: detection of genotoxicity by a fluorescence-based recombination test in mammalian cells.

  2003cites this paper
• Mouse models for induced genetic instability at endogenous loci

  2003cites this paper
• In vivo transgenic mutation assays.

  2003cites this paper
• Transmission of mutations in the lacI transgene to the offspring of ENU‐treated Big Blue® male mice

  2002cites this paper
• Elevated mutant frequencies and predominance of G:C to A:T transition mutations in Msh6−/− small intestinal epithelium

  2002cites this paper
• Comparison of the mutant frequencies and mutation spectra of three non-genotoxic carcinogens, oxazepam, phenobarbital, and Wyeth 14,643, at the lambdacII locus in Big Blue transgenic mice.

  2001cites this paper
• Spontaneous mutation of the lacI transgene in rodents: Absence of species, strain, and insertion‐site influence

  2001cites this paper
• Complementary Genetic Toxicology Assays

  2001cites this paper
• Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.

  2001cites this paper
• N-NITROSODIMETHYLAMINE: HAZARD CHARACTERIZATION AND EXPOSURE–RESPONSE ANALYSIS

  2001cites this paper
• Trangenic fish as models in environmental toxicology.

  2001cites this paper
• Induction of the SAPK activator MIG‐6 by the alkylating agent methyl methanesulfonate

  2001cites this paper
• Further characterization and validation of gpt delta transgenic mice for quantifying somatic mutations in vivo

  2001cites this paper
• Mutation frequency in the lacI gene of liver DNA from lambda/lacI transgenic mice following the interaction of PCBs with iron causing hepatic cancer and porphyria.

  2000cites this paper
• Detection of mutations in transgenic fish carrying a bacteriophage lambda cII transgene target.

  2000cites this paper
• In vivo transgenic mutation assays

  2000cites this paper
• Recent advances in the protocols of transgenic mouse mutation assays.

  2000cites this paper
• Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene.

  2000cites this paper
• Hepatic gene mutations induced in Big Blue™ rats by both the potent rat liver Azo‐carcinogen 6BT and its reported noncarcinogenic analogue 5BT

  1999cites this paper
• Development of a mouse cell line containing the PhiX174 am3 allele as a target for detecting mutation.

  1999cites this paper
• Procarbazine genotoxicity in the MutaMouse; strong clastogenicity and organ-specific induction of lacZ mutations.

  1999cites this paper
• Multiple organ mutation in the lacZ transgenic mouse (Muta mouse) 6 months after oral treatment (5 days) with benzo[a]pyrene.

  1999cites this paper
• Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived.

  1999cites this paper
• Mutational spectrum of dimethylnitrosamine in the liver of 3‐ and 6‐week‐old lacI transgenic mice

  1999cites this paper
• Oxazepam is mutagenic in vivo in Big Blue transgenic mice.

  1999cites this paper
• Induction of mutations in transgenic animal models: BigBlue and Muta Mouse.

  1999cites this paper
• Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of MutaMice treated with 5,9-dimethyldibenzo[c,g]carbazole.

  1999cites this paper
• Effect of mitogenic or regenerative cell proliferation on lacz mutant frequency in the liver of MutaTMMice treated with 5, 9-dimethyldibenzo[c,g]carbazole.

  1999cites this paper
• Mutation induction by N-propyl-N-nitrosourea in eight MutaMouse organs.

  1999cites this paper
• Hepatocarcinogenesis (Z#2)/mutagenesis during initiation stage.

  1998cites this paper
• Hepatic lacI and cII mutation in transgenic (λLIZ) rats treated with dimethylnitrosamine

  1998cites this paper
• Specific mutational spectrum of dimethylnitrosamine in the lacI transgene of Big Blue C57BL/6 mice.

  1998cites this paper
• Bone marrow and liver mutagenesis in lacZ transgenic mice treated with hexavalent chromium.

  1998cites this paper
• Spontaneous mutation in lacI transgenic mice: a comparison of tissues.

  1998cites this paper
• DNA adducts, mutant frequencies and mutation spectra in lambda lacZ transgenic mice treated with N-nitrosodimethylamine.

  1998cites this paper
• Lack of mutagenicity of levofloxacin in lacZ transgenic mice.

  1998cites this paper
• Relative activities of methyl methanesulphonate (MMS) as a genotoxin, clastogen and gene mutagen to the liver and bone marrow of Muta™Mouse mice

  1998cites this paper
• The role of proliferation in the origin of mutations in mammalian cells.

  1998cites this paper
• Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts.

  1998cites this paper
• Mutational response at the splenic T‐Lymphocyte hprt locus in mice treated as neonates: Contrasting effects of the carcinogens N‐ethyl‐N‐nitrosourea, dimethylnitrosamine, and 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine

  1998cites this paper
• The prevention of cancer.

  1998cites this paper
• Hepatic lacI and cII mutation in transgenic (lambdaLIZ) rats treated with dimethylnitrosamine.

  1998cites this paper
• Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice

  1997cites this paper
• Prioritization of possible carcinogenic hazards in food

  1997cites this paper
• Effect of ethylnitrosourea and methyl methanesulfonate on mutation frequency in Muta Mouse germ cells (seminiferous tubule cells and epididymis spermatozoa).

  1997cites this paper
• The causes and prevention of cancer: gaining perspective.

  1997cites this paper
• The response of germ cells to ethylene oxide, propylene oxide, propylene imine and methyl methanesulfonate is a matter of cell stage‐related DNA repair

  1997cites this paper
• Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats.

  1997cites this paper
• Germ cell mutagenesis in lacZ transgenic mice treated with methyl methanesulfonate.

  1997cites this paper
• Guidelines for Canadian Drinking Water Quality Guideline

  1997cites this paper
• Sources of variability in mutant frequency determinations in different organs of lacZ plasmid‐based transgenic mice: Experimental features and statistical analysis

  1997cites this paper
• DNA damage and mutagenesis induced by procarbazine in lambda lacZ transgenic mice: evidence that bone marrow mutations do not arise primarily through miscoding by O6-methylguanine.

  1997cites this paper
• Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.

  1997cites this paper
• Methods for predicting carcinogenic hazards: new opportunities coming from recent developments in molecular oncology and SAR studies.

  1997cites this paper
• Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol.

  1997cites this paper
• Carcinogens induce reversion of the mouse pink-eyed unstable mutation.

  1997cites this paper
• Non‐mammalian and environmental sentinels in human health: “Back to the future?”;

  1997cites this paper
• Analysis of tissue-specific lacZ mutations induced by N-nitrosodibenzylamine in transgenic mice.

  1997cites this paper
• Evaluation of spontaneous and chemical-induced lacI mutations in germ cells from lambda/lacI transgenic mice.

  1997cites this paper
• DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance.

  1997cites this paper
• A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.

  1996cites this paper
• Cancer prevention, rodent high-dose cancer tests, and risk assessment.

  1996cites this paper
• Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.

  1996cites this paper
• Aflatoxin B1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone.

  1996cites this paper
• Frequent spontaneous deletions at a shuttle vector locus in transgenic mice.

  1996cites this paper
• A novel lacI transgenic mutation-detection system and its application to establish baseline mutation frequencies in the scid mouse.

  1996cites this paper
• System issues: Mutagenic response to benzene and Tris(2,3‐dibromopropyl)‐phosphate in the lambda lacl transgenic mouse mutation assay: A standardized approach to in vivo mutation analysis

  1996cites this paper
• 3 Carcinogenicity

  1996cites this paper
• Alternatives to the 2-species bioassay for the identification of potential human carcinogens

  1996cites this paper
• Chrysotile asbestos fibers mediate homologous recombination in Rat2 lambda fibroblasts: implications for carcinogenesis.

  1996cites this paper
• System issues: Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice

  1996cites this paper
• System issues: Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue® mice

  1996cites this paper
• Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.

  1996cites this paper
• Validation issues for the use of transgenic mouse mutation assays in risk assessment.

  1996cites this paper
• System issues: A test for neutrality of mutations of the lacZ transgene

  1996cites this paper
• Spontaneous and ethylnitrosourea-induced mutation fixation and molecular spectra at the lacI transgene in the Big Blue rat-2 embryo cell line.

  1996cites this paper
• Tissue specificity of spontaneous point mutations in lambda supF transgenic mice.

  1996cites this paper
• The Use of lacI Transgenic Mice in Genetic Toxicology

  1996cites this paper
• Other transgenic mutation assays: Tissue specificity of spontaneous point mutations in λsupF transgenic mice

  1996cites this paper
• System issues: Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue™ transgenic mouse mutation assay

  1996cites this paper
• System issue: Spontaneous and ethylnitrosourea‐induced mutation fixation and molecular spectra at the lacl transgene in the Big Blue® Rat‐2 embryo cell line

  1996cites this paper
• Evidence for in vivo non-mutagenicity of the carcinogen hydrazine sulfate in target tissues of lacZ transgenic mice.

  1995cites this paper
• Transgenic models of hepatic growth regulation and hepatocarcinogenesis

  1995cites this paper